Healthy4Baby: Preventing Postpartum Weight Retention Among Low-Income, Black Women

Sponsor
Temple University (Other)
Overall Status
Completed
CT.gov ID
NCT01530776
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
66
1
2
50
1.3

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the feasibility and efficacy of an electronically-mediated, pregnancy and postpartum, behavioral intervention program, compared to usual obstetric care, on changes in weight and cardiometabolic biomarkers among overweight and obese Black women.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Healthy Lifestyle Group
Phase 2

Detailed Description

Black women are in particular need for obesity prevention and treatment. Targeting the childbearing period has the potential to slow the accumulation of weight gain among this high risk group. Previous interventions to prevent postpartum weight retention among Blacks are sparse and limited by poor intervention adherence, high attrition, and failure to include pregnancy in the study design. The proposed research aims to overcome these shortcomings by developing an intervention that 1) focuses solely on Black women, 2) incorporates Black mothers' information needs, values, and social context, 3) uses technology to facilitate participant engagement, and 4) includes both the pregnancy and postpartum periods.

Study Design

Study Type:
Interventional
Actual Enrollment :
66 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Preventing Postpartum Weight Retention Among Low-Income, Black Women
Study Start Date :
Jan 1, 2012
Actual Primary Completion Date :
Mar 1, 2016
Actual Study Completion Date :
Mar 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Healthy Lifestyle Group

Participants randomized to this condition will receive information and strategies to help them eat healthier and be more active during and after pregnancy. They will get this information about eating and activity through handouts, text messages, Facebook updates, and in-person visits and phone calls from a health coach.

Behavioral: Healthy Lifestyle Group
Electronically-mediated, behavioral intervention during and after pregnancy encouraging mothers to eat healthy, exercise, and return to their early pregnancy weights by 1 year postpartum

No Intervention: Usual Care

This condition is meant to represent standard clinical care provided to pregnant and postpartum mothers at Temple University.

Outcome Measures

Primary Outcome Measures

  1. Change in maternal weight from early pregnancy (< 20 weeks gestation) to 6 months and 1 year postpartum [Approximately 18 months]

Secondary Outcome Measures

  1. Change in maternal weight from early pregnancy to delivery [Approximately 6 months]

  2. Change in maternal cardiometabolic biomarkers and additional anthropometrics (insulin sensitivity and secretion, fasting lipids, blood pressure, waist circumference) from early pregnancy to 6 months and 1 year postpartum [Approximately 18 months]

  3. Change in infant weight and length from birth to 6 months and 1 year of age [Approximately 12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Pregnant African-American women at least 18 years of age

  2. BMI at recruitment between 25.0-44.9 kg/m2

  3. Singleton pregnancy

  4. Gestational age of ≤ 20 weeks as determined by last menstrual period

  5. Plan to carry the pregnancy to term and keep the baby

  6. Own a cell phone with a text messaging plan

  7. Member of Facebook social networking site

  8. Able to participate in physical activity

  9. Participants must be willing to comply with all study-related procedures

Exclusion Criteria:
  1. BMI ≤ 24.9 or ≥ 45.0

  2. Uncontrolled hypertension (systolic blood pressure > 160 or diastolic blood pressure > 95 mmHg). Participants with controlled hypertension on medication for at least three months are allowable.

  3. Known atherosclerotic cardiovascular disease

  4. Known congestive heart failure

  5. Known diabetes mellitus (type 1 or type 2)

  6. Uncontrolled thyroid disease. Participants with controlled thyroid disease on medication for at least three months are allowable.

  7. Known cancer

  8. Any major active rheumatologic, pulmonary, hepatic, dermatologic disease or inflammatory condition requiring steroids or immune modulating medications

  9. History of testing HIV positive

  10. Current smoker or tobacco user

  11. Current or recent history (past 6 months) of drug or alcohol abuse or dependence

  12. Participation in any weight control or investigational drug study within 6 weeks of screening

  13. Serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's safety for successful study participation

  14. Gastrointestinal Disorders (gallbladder disease, Crohn's disease, etc)

  15. Previous weight loss surgery

  16. History of bulimia or anorexia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Temple University Philadelphia Pennsylvania United States 19140

Sponsors and Collaborators

  • Temple University
  • National Heart, Lung, and Blood Institute (NHLBI)

Investigators

  • Principal Investigator: Sharon J. Herring, MD, MPH, Temple University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Temple University
ClinicalTrials.gov Identifier:
NCT01530776
Other Study ID Numbers:
  • 20227
  • K23HL106231
First Posted:
Feb 10, 2012
Last Update Posted:
May 21, 2018
Last Verified:
May 1, 2018
Keywords provided by Temple University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 21, 2018